Ethylene Glycol

Ethylene Glycol

SCHEMBL11969729

C=C.C=C.C=C.C=C.C=C.CCOC.OCCO

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.40
TSHR P16473 2/20 0.36
PPARD Q03181 2/20 0.32
ROCK2 O75116 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethylene Glycol SCHEMBL2795498 1.00 ALDH1A1 (0.40) ALDH1A1TSHRPPARDROCK2SMN1; SMN2
Ethylene Glycol SCHEMBL11969844 1.00 ALDH1A1 (0.40) ALDH1A1TSHRPPARDROCK2SMN1; SMN2
Ethylene Glycol SCHEMBL18548408 1.00 ALDH1A1 (0.40) ALDH1A1TSHRPPARDROCK2SMN1; SMN2
Ethylene Glycol SCHEMBL309943 0.93
Butane SCHEMBL7198858 0.86 ALDH1A1 (0.40) ALDH1A1TSHRPPARDROCK2SMN1; SMN2
Ethylene Glycol SCHEMBL310105 0.84 ALDH1A1 (0.35) ALDH1A1TSHR
Ethylene Glycol SCHEMBL15387103 0.84 ALDH1A1 (0.35) ALDH1A1TSHR
Ethylene Glycol SCHEMBL21353746 0.83 ALDH1A1 (0.38) ALDH1A1TSHRPPARD
Ether SCHEMBL10456957 0.83 ALDH1A1 (0.53) ALDH1A1TSHRPPARD
Di(Hydroxyethyl)Ether SCHEMBL28430914 0.82 ALDH1A1 (0.60) ALDH1A1TSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12597635-B2 Electrochemical device MURATA MANUFACTURING CO., LTD. (JP) 2026-04-07 US disclosed
US-12095081-B2 Electrolytic solution and electrochemical device MURATA MANUFACTURING CO., LTD. (JP) 2024-09-17 US disclosed
US-20240014378-A1 POSITIVE ELECTRODE AND ELECTROCHEMICAL DEVICE MURATA MANUFACTURING CO., LTD. (JP) 2024-01-11 US disclosed
US-20230223525-A1 ELECTROCHEMICAL DEVICE MURATA MANUFACTURING CO., LTD. (JP) 2023-07-13 US disclosed
WO-2022209595-A1 POSITIVE ELECTRODE AND ELECTROCHEMICAL DEVICE 株式会社村田製作所 2022-10-06 WO disclosed
EP-3832772-A1 ELECTROLYTIC SOLUTION AND ELECTROCHEMICAL DEVICE Murata Manufacturing Co., Ltd. (JP) 2021-06-09 EP disclosed
US-20210151803-A1 ELECTROLYTIC SOLUTION AND ELECTROCHEMICAL DEVICE MURATA MANUFACTURING CO., LTD. (JP) 2021-05-20 US disclosed
EP-2495797-A1 NONAQUEOUS ELECTROLYTE SOLUTION FOR SECONDARY BATTERY, AND SECONDARY BATTERY Asahi Glass Company, Limited (JP) 2012-09-05 EP disclosed
US-20120214073-A1 NON-AQUEOUS ELECTROLYTE SOLUTION FOR SECONDARY BATTERIES, AND SECONDARY BATTERY ASAHI GLASS COMPANY, LIMITED (JP) 2012-08-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12597635-B2 Electrochemical device CLCN2, HCN4, SLC26A3 ALDH1A1 2350/4885TSHR 1300/4885PPARD 792/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.